FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/068198 [Registered on: 31/05/2024] Trial Registered Prospectively
Last Modified On: 21/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Biological 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison Between The Effectiveness Of Two Types Of Blood Concentrates In Facial Scars.  
Scientific Title of Study   A Comparative Study On Efficacy Of Injectable Platelet Rich Fibrin (i-PRF) And Platelet Rich Plasma (PRP) In Facial Scars - A Triple Blinded Randomized Clinical Trail. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Narasimhadevara Santha Lakshmi Pratyusha 
Designation  post graduate 
Affiliation  Anil Neerukonda Institute Of Dental Sciences 
Address  Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Visakhapatnam

Visakhapatnam
ANDHRA PRADESH
531162
India 
Phone  8187820402  
Fax    
Email  pratyusha2820046@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr K Phani Kumar 
Designation  Professor and Head of Department  
Affiliation  Anil Neerukonda Institute Of Dental Sciences 
Address  Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Visakhapatnam

Visakhapatnam
ANDHRA PRADESH
531162
India 
Phone  8096339404  
Fax    
Email  raghu8099@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr I Nagamalleswara Rao 
Designation  Professor 
Affiliation  Anil Neerukonda Institute Of Dental Sciences 
Address  Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Visakhapatnam

Visakhapatnam
ANDHRA PRADESH
531162
India 
Phone  9618170810  
Fax    
Email  malli.maxface@gmail.com  
 
Source of Monetary or Material Support  
Anil Neerukonda Institute of Dental Sciences, Sangivalasa, Visakhapatnam, Andhra Pradesh,India 531162 
 
Primary Sponsor  
Name  Anil Neerukonda Institute of Dental Sciences  
Address  Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Sangivalasa, Visakhapatnam, Andhra Pradesh, India 531162 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Narasimhadevara Santha Lakshmi Pratyusha  Anil Neerukonda Institute of Dental Sciences   Room no 3, Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Visakhapatnam
Visakhapatnam
ANDHRA PRADESH 
8187820402

pratyusha2820046@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE- Anil Neerukonda Institute of Dental Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S019||Open wound of unspecified part ofhead,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Injectable - Platelet Rich Fibrin (i-PRF)  blood will be collected into a plain vacutainer from the participant and will be centrifuged at 700rpm from 3min and i-PRF is extracted and will be injected into the facial scar 
Comparator Agent  Platelet Rich Plasma (PRP)  blood will be collected into a EDTA vacutainer from the participant and will be centrifuged, 1st step at 900rpm for 5min and 2nd step at 2000rpm for 15min. PRP is taken and will be injected into the facial scar 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1. Scars secondary to surgical incision and trauma.
2. Scars involving head and neck region.
3. Patients willing to participate in the study.
 
 
ExclusionCriteria 
Details  1. Scars secondary to burns, acne.
2. Scars that received any previous revision/treatment.
3. Patients with history keloid tendency, any active skin/systemic conditions, immunosuppression, bleeding and clotting disorders, pregnancy.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
surface area of the scar  1 month 
 
Secondary Outcome  
Outcome  TimePoints 
pigmentation and texture  1 month 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [pratyusha2820046@gmail.com].

  6. For how long will this data be available start date provided 01-07-2024 and end date provided 01-12-2029?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

1. Aim of this study is to compare the efficacy between Injectable Platelet-Rich Fibrin (i-PRF) and Platelet-Rich Plasma (PRP) in the treatment of Facial Scars. Patients who report with chief complaint of facial scar to the Department of Oral and Maxillofacial Surgery, Anil Neerukonda Institute of Dental Sciences, Visakhapatnam. Careful evaluation & selection of participants. Written Informed Consent will be taken from selected participants & Preoperative Patient and Observer Scar Assessment Scale (POSAS) will be taken respectively. The co- investigator will be helping in blinding and allocation concealment. The participants will be randomly assigned to Group A & Group B. Both the Principal Investigator and Participant will be blinded. The Co-investigator will be helping with randomization, blinding and Allocation concealment. The Evaluator, who is blinded, will assess Postoperative outcomes one month after the last session in all the participants from both the groups by Patient and Observer Scar Assessment Scale (POSAS). The collected data will be consolidated and statistically analyzed.

3. 

 
Close